PMDA — authorised 23 December 2022
- Marketing authorisation holder: Mochida Pharmaceutical Co., Ltd.
- Status: approved
🇯🇵 Remodulin in Japan
PMDA authorised Remodulin on 23 December 2022
Marketing authorisation
Remodulin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in Japan
Frequently asked questions
Is Remodulin approved in Japan?
Yes. PMDA authorised it on 23 December 2022.
Who is the marketing authorisation holder for Remodulin in Japan?
Mochida Pharmaceutical Co., Ltd. holds the Japanese marketing authorisation.